Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07296783

Transforming Research and Clinical Knowledge in Geriatric Traumatic Brain Injury (TRACK-GERI)

The purpose of this study is to improve the diagnosis and prediction of recovery after traumatic brain injury (TBI) in adults age 65 years and older. The study will follow older adults who present to the emergency department after TBI, as well as matched control participants, and will measure clinical features, brain imaging, and blood-based biomarkers over 12 months to understand how recovery changes over time. Researchers will examine how pre-injury health, brain structure, and biological markers are related to disability and cognitive outcomes after TBI. Information from this study will be used to develop age-appropriate tools to better diagnose TBI and estimate long-term outcomes in older adults.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

San Francisco Veterans Affairs Medical Center, San Francisco, California, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

TRACK-GERI/VA TBI PATIENT INCLUSION/EXCLUSION CRITERIA

Inclusion criteria

  • Age 65 years and older, no upper age limit
  • Reliable report or physical evidence of head trauma
  • Injury occurred <72 hours ago (within 14 days of injury for TRACK-VA TBI patients)
  • Acute brain CT for clinical use
  • Fluency in English/Chinese (UCSF only)
  • Ability to obtain informed consent from subject or legally authorized representative
  • Ability to be co-enrolled with a study partner who meets Study Partner enrollment criteria

Exclusion criteria

  • Significant polytrauma that would interfere with follow-up and outcome assessment
  • Prisoners or patients in custody
  • Patients on psychiatric hold (e.g. 5150, 5250)
  • Low likelihood follow-up (participant or family is indicating a low interest, homelessness, out of state/country)
  • Current participation in an interventional trial
  • Penetrating TBI
  • Spinal cord injury with ASIA score of C or worse
  • Acute disabling neurological injury (e.g. acute stroke, cardiac arrest concurrent with head trauma presentation)

TRACK-GERI/VA STUDY PARTNERS OF TBI PATIENTS INCLUSION/EXCLUSION CRITERIA

Inclusion criteria

  • Age 18 years or older
  • Either designated by the patient, presents with patient to the Emergency Department, is listed in the patient's medical chart as an alternate/emergency contact, or is the patient's case manager/social worker, and knows the patient well enough to comment on the patient's health and functional status (e.g. may be family member, friend, caregiver, case manager, etc).
  • Ability to read, write, and speak English/Chinese (UCSF only)
  • Ability to provide informed consent for self

Exclusion criteria

  • Pre-existing and major disabling medical, psychiatric, or other neurological disease (e.g. dementia) that interferes with ability to provide evaluation of patient's health and functional status.
  • Prisoners or patients in custody
  • Patients on psychiatric hold (e.g. 5150, 5250)

TRACK-GERI/VA CONTROL SUBJECT INCLUSION/EXCLUSION CRITERIA

Inclusion criteria

  • Age 65 years or older, no upper age limit
  • Visual acuity/hearing adequate for testing
  • Fluency in English/Chinese (UCSF only)
  • Ability to obtain informed consent from subject or legally authorized representative
  • Ability to be co-enrolled with a study partner who meets study partner enrollment criteria (see control study partner enrollment criteria)
  • For TRACK-VA patients only: Presentation to SFVAMC ED for acute care with planned discharge from ED.

Exclusion criteria

  • Medically diagnosed with traumatic brain or orthopedic injury in the last year (TRACK-VA Control Subjects are not excluded for orthopedic injuries)
  • Significant polytrauma that would interfere with follow-up and outcome assessment
  • Prisoners or patients in custody
  • Patients on psychiatric hold (e.g. 5150, 5250)
  • Low likelihood follow-up (participant or family is indicating low interest, homelessness, out of state/country)
  • Current participation in an interventional trial
  • Penetrating TBI
  • Spinal cord injury with ASIA score of C or worse
  • Acute disabling neurological injury (e.g. acute stroke, cardiac arrest)

TRACK-GERI/VA STUDY PARTNERS OF CONTROL SUBJECTS INCLUSION/EXCLUSION CRITERIA

Inclusion criteria

  • Age 18 years or older
  • Designated by the control subject as someone who knows the subject well enough to comment on their health and functional starus (e.g., may be family member, friend, caregiver, case manager, etc.)
  • Ability to read, write and speak English/Chinese (UCSF only)
  • Ability to provide informed consent for self

Exclusion criteria

  • Pre-existing and major disabling medical, psychiatric, or other neurological disease (e.g. dementia) that interferes with ability to provide evaluation of control subject's health and functional status.
  • Prisoners or in custody
  • On psychiatric hold (e.g. 5150, 5250)

Treatment and study plan

Primary outcomes

  1. Functional Outcome at 6 Months Post-Injury as Assessed by the Glasgow Outcome Scale-Extended (GOSE)

    Time frame: 6 months post-injury

    Functional outcome after traumatic brain injury will be measured using the Glasgow Outcome Scale-Extended (GOSE). The score ranges from 1-8, with higher scores indicating better recovery. The primary outcome is GOSE assessed at 6 months post-injury.

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • Doris Duke Charitable Foundation
  • National Institute of Neurological Disorders and Stroke (NINDS)
  • National Institute on Aging (NIA)
  • US Department of Veterans Affairs
  • United States Department of Defense

Registry information

Acronym: TRACK-GERI

Important dates

Study start
2019
Primary completion
2027
Study completion
2027
First posted
Dec 22, 2025
Registry last updated
Dec 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.